Immune cell and serum cytokine dynamics in islet transplant recipients receiving Belatacept/Sirolimus versus Tacrolimus/Mycophenolate (TTS 2026) - Sep 17, 2026 - Pres time: Sep 23, 2026; 08:42 AM - 08:47 AM; Location: Room C4.7; 411; "Bela/Siro promotes early enrichment of regulatory immune subsets, including Tregs, pDCs and Breg-like cells, with distinct CD8+T-cell and innate immune recovery patterns, while maintaining comparable systemic cytokine profiles. These immunoregulatory features may contribute to improved transplant outcomes."
Clinical • Immune cell • Transplantation • B3GAT1 • CD27 • CD8 • FOXP3 • GZMA • IFNG • IL10 • IL17A • IL2 • IL4 • IL6 • TNFA
|
|
Rachel Cheong1; Hugh Gabor1; Elvira Jimenez-Vera1; Noah Kentmann1; Brian Gloss2; Xuan Han1; Xinyi Ding1; Preeti Sharma1; Patricia Anderson3; Thomas Loudovaris4; Colleen Etherton5; Wayne Hawthorne1; Jane Holmes-Walker6; David Torpy5; David Goodman4; Stephen Alexander7; Toby Coates5; Thomas Kay4; Natasha Rogers1,3; Philip O'Connell1; Min Hu1
|